Article

Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating…

Evidence-Based Complementary and Alternative Medicine · 2022 · Yanan Li, author Jingyi Hu, author Cheng Cheng, author Feng Xu, author Ryan Au, author Lei Zhu, author Hong Shen, author Guang Chen, Academic Editor

Key facts

Title Baicalin Ameliorates DSS-Induced Colitis by Protecting Goblet Cells through Activating NLRP6 Inflammasomes
First author Yanan Li, author Jingyi Hu, author Cheng Cheng, author Feng Xu, author Ryan Au, author Lei Zhu, author Hong Shen, author Guang Chen, Academic Editor
Journal Evidence-Based Complementary and Alternative Medicine
Published Jun 9, 2022
DOI 10.1155/2022/2818136
Devices mentioned K913963, K926106
Product codes mentioned GIA, JLW, JNB

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature